XETRA - Delayed Quote • EUR
Evotec SE (EVT.DE)
At close: April 26 at 5:35 PM GMT+2
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 9 | 10 |
| Avg. Estimate | 0.02 | 0.02 | 0.2 | 0.53 |
| Low Estimate | 0.02 | 0.02 | 0.09 | 0.39 |
| High Estimate | 0.03 | 0.02 | 0.34 | 0.89 |
| Year Ago EPS | -0.08 | -0.08 | -0.47 | 0.2 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 12 | 12 |
| Avg. Estimate | 226.5M | 216.5M | 922.4M | 1.07B |
| Low Estimate | 223M | 199M | 828.4M | 900.5M |
| High Estimate | 230M | 234M | 972M | 1.15B |
| Year Ago Sales | -- | -- | 781.43M | 922.4M |
| Sales Growth (year/est) | -- | -- | 18.00% | 16.40% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.41 | -0.04 | -0.06 | 0.02 |
| EPS Actual | -0.08 | -0.08 | -0.22 | -0.09 |
| Difference | 0.33 | -0.04 | -0.16 | -0.11 |
| Surprise % | 80.50% | -100.00% | -266.70% | -550.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.02 | 0.02 | 0.2 | 0.53 |
| 7 Days Ago | 0.02 | 0.02 | 0.19 | 0.51 |
| 30 Days Ago | 0.02 | 0.02 | 0.24 | 0.52 |
| 60 Days Ago | 0.02 | 0.02 | 0.24 | 0.55 |
| 90 Days Ago | 0.02 | 0.02 | 0.24 | 0.55 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | EVT.DE | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 125.00% | -- | -- | 6.50% |
| Next Qtr. | 125.00% | -- | -- | 12.00% |
| Current Year | 142.60% | -- | -- | 5.30% |
| Next Year | 165.00% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -32.54% | -- | -- | 11.09% |
| Past 5 Years (per annum) | 124.92% | -- | -- | -- |
Research Analysis
Related Tickers
AQST Aquestive Therapeutics, Inc.
4.0700
+3.56%
MRK.DE Merck KGaA
151.75
+1.10%
SBX.DE SynBiotic SE
9.86
+8.83%
SDZ.SW Sandoz Group AG
30.00
-2.31%
SBX.MU SynBiotic SE
9.56
+4.60%
ITCI Intra-Cellular Therapies, Inc.
73.26
+1.57%
SBFM Sunshine Biopharma, Inc.
0.9500
+17.66%
IP4.F InnoCan Pharma Corporation
0.1900
+2.98%
DMP.DE Dermapharm Holding SE
31.30
+0.81%
NBIX Neurocrine Biosciences, Inc.
135.99
-1.28%